Sudden cardiac death (SCD) in young athletes engaged in regular intensive training represents a rare but highly significant clinical and social problem. Although the incidence is low, SCD typically occurs unexpectedly during physical exertion or shortly thereafter, often as the first manifestation of previously undiagnosed cardiovascular disease. The main etiological factors include hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, dilated cardiomyopathy, and primary electrical disorders such as long QT syndrome. Risk stratification is based on a comprehensive approach that involves clinical history, physical examination, resting and exercise electrocardiography (ECG), echocardiography, and, in selected cases, genetic testing. Recent consensus statements highlight the importance of improving ECG interpretation criteria to reduce false-positive results in athletes. Preventive strategies include pre-participation cardiovascular screening, continuous follow-up of high-risk groups, and timely intervention in suspected cases. Equally important are emergency measures, including cardiopulmonary resuscitation and rapid use of automated external defibrillators, which significantly improve survival outcomes. Awareness of potential risk factors, combined with optimized screening protocols and personalized decision-making, may reduce the incidence of SCD in the athletic population.
| Mualliflar | Турсунов, E, Курбанов, Р, Закиров, Н, Сроджидинова, Н, Расулов, A, Tursunov, Ergashali, Kurbanov, Ravshanbek, Zakirov , Nodir, Srojidinova, Nigora, Rasulov , Alisher, Tursunov, Ergashali, Kurbanov, Ravshanbek, Zakirov , Nodir, Srojidinova, Nigora, Rasulov , Alisher |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2025-12-12 |
| Jild | 2 |
| Son | 4 |
| Betlar | 381-390 |
| Til | Ingliz |
| DOI | 10.70626/cardiouz-2025-2-00069 |
DOI: 10.70626/cardiouz-2025-2-00069 · Maqolaning asl sahifasi
sudden cardiac death, athletes, risk factors, screening, channelopathies, Внезапная сердечная смерть, спортсмены, факторы риска, скрининг, каналопатии, tosatdan yurak o`limi, sportchilar, xavf omili, skrining, kanalopatiyalar
Aim. To evaluate the influence of combined hypolipidemic therapy (statins in combination with ezetimibe and fenofibrate) and sodium-glucose cotransporter 2 inhibitors on epicardial fat thickness in patients with…
In the modern ESH (2023) and ESC (2024) guidelines on arterial hypertension (AH), the following key provisions for the use of combination therapies from the start of treatment have been clearly formulated for the first…
Aim. To evaluate the immediate clinical and angiographic success in patients with NSTEMI, who underwent percutaneous coronary intervention (PCI) with the installation of a new generation of resorbable scaffolds…
Aim. To evaluate the effectiveness of percutaneous coronary intervention (PCI) in patients with ischemic cardiomyopathy and identify opportunities for its improvement, as well as to conduct a comparative analysis with…
Aim. To assess the prevalence of atherosclerotic lesions of the brachiocephalic arteries (BCA), their association with cardiovascular risk factors, and cardiovascular risk according to the SCORE scale in the population…
Aim. Systematic analysis and comparison of different reperfusion therapy methods in patients with ST-elevation acute coronary syndrome (STEMI), including primary percutaneous coronary intervention (pPCI) and…
Purpose: to determine the clinical and epidemiological characteristics and laboratory and instrumental research indicators, the profile of cardiovascular risk factors in patients who have suffered myocardial infarction…
Aim. To evaluate the effectiveness of ulinastatin as part of complex therapy in reducing the incidence of early postoperative complications in patients with multivessel coronary artery disease after CABG. Materials and…
Aim. To systematically analyze current approaches to assessing and improving medication adherence in patients after acute myocardial infarction during outpatient follow-up, with a particular focus on factors influencing…
Obstructive hypertrophic cardiomyopathy (OHCMP) is a disease characterized by cardiac remodeling due to genetic factors. OHCMP can cause the development of dynamic obstruction in the outflow tract of the left ventricle…